Skip to main content
Clinical Trials/NCT06098729
NCT06098729
Completed
Not Applicable

Informatics-Based Digital Intervention to Promote Safe Exercise in Middle-Aged Adults With Type 1 Diabetes and Other Absolute Insulin Deficiency Diabetes - A Feasibility Study

Yale University1 site in 1 country24 target enrollmentNovember 2, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Type 1 Diabetes
Sponsor
Yale University
Enrollment
24
Locations
1
Primary Endpoint
Feasibility of Usage
Status
Completed
Last Updated
7 months ago

Overview

Brief Summary

The challenges of living with type 1 diabetes often stand in the way of getting enough exercise. Continuous blood sugar monitoring has revolutionized type 1 diabetes care but remains underutilized to sustainably support exercise and related behaviors. This research will develop a mobile application that delivers personalized encouragement and data-driven health insights based upon patterns in blood sugar, exercise, mood, and sleep, to assist people with type 1 diabetes in exercising more frequently and confidently.

Registry
clinicaltrials.gov
Start Date
November 2, 2023
End Date
October 25, 2024
Last Updated
7 months ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Diagnosis with type 1 diabetes (T1D) or other insulin deficiency diabetes (latent autoimmune disease of adulthood, diabetes secondary to pancreatitis)
  • Low exercise levels
  • Smartphone ownership
  • English literacy
  • Under regular care by a healthcare provider
  • Home Broadband wireless Internet or cell phone network (≥25 mbps downloads, ≥3 mbps uploads)

Exclusion Criteria

  • Diabetic ketoacidosis not clearly related to pump site failure in past 6 months
  • \>1 episode of severe hypoglycemia (altered mental and/or physical status requiring assistance from another person for recovery) in past 6 months
  • A1c ≥10.0%
  • Resting blood pressure \>145mmHg systolic or \>90 mmHg diastolic
  • Myocardial infarction or angina in past 6 months
  • Renal failure
  • Pregnancy
  • Cognitive impairment
  • Severe retinopathy or neuropathy.
  • Other chronic disease or physical disability that would influence exercise intervention

Outcomes

Primary Outcomes

Feasibility of Usage

Time Frame: 4 weeks

Minutes of using application to exercise. 0 minutes/week is the lowest value, 150 minutes/week meets clinically recommended amounts.

Acceptability

Time Frame: 4 weeks

Likert-style survey of participant satisfaction. Responses are on a scale from 1 (very dissatisfied) to 5 (very satisfied)

Accuracy

Time Frame: 4 weeks

Accuracy to predict lapses in exercise behavior ahead of time. 50% accuracy is the lowest possible value (ie, equivalent to random guessing), 80% accuracy is the goal of the study, and 100% accuracy would be the highest possible accuracy. This is the single outcome of a regression analysis across the entire sample. Being a single outcome, there is no measure of dispersion.

Secondary Outcomes

  • Motivation States for Physical Activity(6 weeks)
  • Moderate to Vigorous Physical Activity(6 weeks)
  • Interview Themes(6 weeks)

Study Sites (1)

Loading locations...

Similar Trials